J&J offers to buy ITCI for $14.6 billion. LLY announces disappointing preliminary sales numbers for the fourth quarter.

Public health nutritionist Dr Emma Derbyshire has explained how to ward off the chances of getting the infection ...

The design for a medical study in 1743 that was never carried out may have inspired James Lind’s groundbreaking clinical ...

(UroToday.com) The 2024 American Society of Clinical Oncology (ASCO) annual meeting featured a session on optimizing treatment for your patient with urothelial cancer, and a presentation by Dr. Brent ...

Audit Wales published a damning report that confirmed what many already knew – that NHS Wales is failing its cancer patients.

General Manager and CEO of Junshi Biosciences, Dr. Jianjun ZOU, said, “Toripalimab has made significant strides in its internationalization. As of today, toripalimab has been approved in 35 countries ...

AstraZeneca's Calquence (acalabrutinib) has been approved by the U.S. FDA for the first-line treatment of adult patients with previously untreate ...

The transition to menopause isn't always easy. Menopause — which usually occurs at around age 50 — officially begins 12 ...

The drugs treat prostate, breast and blood cancers. About 80,000 people with Medicare Part D coverage used them in a one-year ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.